MMP1 rs1799752: Understanding Your Genetic Variant
The rs1799752 variant is located within the MMP1 gene, which encodes a protein responsible for breaking down collagen in the body. Research suggests this variant may influence the expression levels of this enzyme, potentially impacting how skin and other tissues respond to environmental stressors like UV radiation.
What each genotype means
Baseline collagen expression
This genotype represents the reference sequence for the MMP1 promoter region. Research suggests this version of the gene may result in lower baseline and UV-induced expression of the MMP1 enzyme compared to the 2G allele. This is considered the standard genetic background for collagen regulation in many populations.
Carried by approximately 30% of individuals globally, though frequencies vary significantly by ancestry.
Intermediate collagen regulation
Carrying one copy of the 2G allele may lead to a moderate increase in MMP1 promoter activity. This variant, often referred to in literature as the 1G/2G polymorphism, is associated with potentially higher levels of matrix metalloproteinase expression, which can influence collagen turnover rates in skin and other connective tissues.
This heterozygous genotype is common, found in roughly 40-50% of the global population.
Enhanced collagen degradation potential
This genotype contains two copies of the 2G insertion, which has been shown in laboratory studies to create a binding site for transcription factors that increase MMP1 expression. Higher levels of MMP1 are associated with accelerated collagen degradation, which may contribute to skin aging or structural changes in connective tissue. These findings are based on limited evidence and individual outcomes are influenced by many environmental and genetic factors.
Carried by roughly 20-25% of the global population, with higher prevalence observed in certain ancestral groups.
What is the rs1799752 Variant?
The rs1799752 variant is a specific change in the DNA sequence located within the MMP1 gene. In genomics, a single nucleotide polymorphism (SNP) like this represents a variation at a single position in the DNA code. This particular variant is situated in the promoter region of the MMP1 gene, which acts as a control switch for how much of the MMP1 protein is produced by your cells. Because it sits in a regulatory area rather than the protein-coding sequence itself, it does not change the structure of the enzyme, but rather influences the frequency or intensity with which the gene is turned on or off. Scientists study these regulatory variants to understand why individuals may have different baseline levels of protein production, which can lead to subtle differences in physiological processes like tissue remodeling and extracellular matrix maintenance.
The Role of the MMP1 Gene
The MMP1 gene provides instructions for making an enzyme called matrix metallopeptidase 1, also known as interstitial collagenase. This enzyme is a member of the matrix metalloproteinase family, which are zinc-dependent endopeptidases. Its primary biological function is to break down interstitial collagens, specifically types I, II, and III, which are the structural proteins that provide strength and elasticity to skin, tendons, and other connective tissues. By degrading these collagens, MMP1 plays a critical role in normal tissue remodeling, wound healing, and the turnover of the extracellular matrix. However, because it is a powerful protease, its activity must be tightly regulated. When the balance of MMP1 production is disrupted, it can lead to excessive degradation of the structural framework of tissues, which is a subject of interest in studies regarding skin aging and the response to ultraviolet (UV) light exposure.
Research Associations and Evidence Strength
Current research into rs1799752 is categorized as having limited evidence regarding its clinical impact. While some studies have explored the association between promoter variants in MMP1 and traits such as skin aging or the formation of wrinkles, these findings are often complex and influenced by many other genetic and environmental factors. The scientific literature suggests that certain variants in this region may enhance baseline or UV-induced expression of the MMP1 enzyme, theoretically driving faster collagen degradation. However, it is important to note that these associations are not definitive. Many studies in this field are observational, and the results can vary significantly between different populations and study designs. Consequently, this variant is not considered a diagnostic marker for any specific medical condition, and its influence on an individual's phenotype remains a topic of ongoing scientific investigation rather than established clinical fact.
Population Frequency
According to data from the gnomAD database, the rs1799752 variant is relatively common, with a global minor allele frequency of approximately 0.45. This high frequency indicates that the variant is widely distributed across diverse human populations. Because it is so common, it is considered a standard part of human genetic variation rather than a rare mutation. The prevalence of the different genotypes (the specific combinations of alleles an individual carries) is generally consistent with this high frequency, meaning that a large portion of the general population carries at least one copy of the variant allele. This widespread distribution is typical for regulatory SNPs that have been maintained in the human gene pool over time, suggesting that the variation does not have a severe impact on survival or reproductive fitness.
What You Can and Cannot Do With This Information
Understanding your genotype for rs1799752 provides a glimpse into your genetic makeup, but it is not a tool for medical diagnosis or personalized health planning. Because the evidence linking this variant to specific physical traits is limited and often mixed, you cannot use this information to predict your skin health or future risk of any condition. Genetic markers are only one piece of a much larger puzzle that includes your lifestyle, diet, sun exposure, and thousands of other genetic variants. If you are concerned about skin health, collagen maintenance, or any other aspect of your physical well-being, the most effective approach is to consult with a dermatologist or a qualified healthcare provider. They can offer evidence-based advice tailored to your specific needs, which is far more reliable than interpreting individual SNP data in isolation. Always prioritize professional medical guidance over self-interpretation of genetic reports.
How common is this variant?
The rs1799752 variant is common globally, with a minor allele frequency of approximately 0.45 according to gnomAD data.
Frequently asked questions
Is rs1799752 a cause of skin aging?
No, rs1799752 is not a direct cause of skin aging. While some research suggests it may influence the expression of collagen-degrading enzymes, skin aging is a complex process driven by many factors including sun exposure, lifestyle, and thousands of other genetic variants.
Can I use this SNP to predict my wrinkle risk?
No, you cannot use this SNP to predict your risk of developing wrinkles. The evidence linking this variant to skin traits is limited and not strong enough to be used for predictive health purposes.
Should I change my skincare routine based on my MMP1 genotype?
You should not change your skincare routine based on this genotype. If you have concerns about your skin, it is best to consult a dermatologist who can recommend products and habits based on your actual skin condition rather than genetic markers.
Is this variant associated with any diseases?
While some studies have explored associations between MMP1 variants and various conditions, the evidence for rs1799752 is not sufficient to link it to any specific disease. Always consult a medical professional for concerns regarding your health.
Sources & further reading
Educational information only, last refreshed 9/22/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1799752?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in ACE
This variant is associated with ACE activity levels, though current CPIC guidelines prioritize other markers for clinical ACE inhibitor dosing.
Exonic variant in ACE often used as a proxy for the ACE insertion/deletion polymorphism affecting circulating ACE enzyme activity.
This variant in the ACE gene is associated with variations in soluble amyloid-beta levels in patients with Alzheimer's disease.
This SNP is being investigated as a potential biomarker for personalized antihypertensive therapy in specific ethnic cohorts.
A variant recently evaluated in pharmacogenomic studies of the Pashtun population to assess its role in antihypertensive drug response.
Coding-region single nucleotide variant in the angiotensin-converting enzyme gene investigated for modulation of baseline exercise test duration and cardiovascular training response.